Connecticut is part of a group of states and local governments that have reached a $1.6 billion settlement with drugmaker Mallinckrodt, over the company’s sale of generic prescription opioids. Connecticut Attorney General William Tong says the business knew that its product was deadly. Over time, the company is expected to pay the money into a fund intended to address the opioid addiction crisis. Mallinckrodt is entering bankruptcy at the same time the settlement is being announced. It would pay some of the money when it comes out of bankruptcy, and the rest of the funds over seven years. It has yet to be determined how much money Connecticut would receive from the fund.
